<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="800">
  <stage>Registered</stage>
  <submitdate>27/09/2005</submitdate>
  <approvaldate>4/10/2005</approvaldate>
  <actrnumber>ACTRN12605000586617</actrnumber>
  <trial_identification>
    <studytitle>A Randomised Trial Of Barretts Ablation: YAG Laser vs Argon Plasma Coagulation</studytitle>
    <scientifictitle>A Randomised Trial Comparing the efficacy of YAG Laser Contact Ablation against Argon Plasma Coagulation in ablating Barretts Oesophagus.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Barrets Oesophagus</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Maximum of 6 ablation treatment sessions per patient, each separated by one month. Follow up at 6 weeks, 6 months and 12 months after ablation therapy completed.</interventions>
    <comparator />
    <control>Active</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Surface area ablated</outcome>
      <timepoint>At 6 weeks, 6 months and 12 months following completion of ablation</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Buried gland rates</outcome>
      <timepoint>At 6 weeks, 6 months and 12 months following completion of ablation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Complications </outcome>
      <timepoint>During the ablation period and at 6 weeks, 6 months and 12 months post ablation.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Biomarker reversibility</outcome>
      <timepoint>At 6 weeks, 6 months and  12 months.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Barretts 3 - 10cm length.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No exclusion criteria</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelopes until intervention assigned</concealment>
    <sequence>Random shuffling of sealed allocation envelopes</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>1/10/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>University of Melbourne Department of Surgery, Austin Hospital</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Local Grant</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>N/A</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Austin Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Ahmad Aly</name>
      <address>Department of Surgery
Austin Hospital
Level 8
Kance Townsend Building (LTB)
Studley Rd
Heidelberg VIC 3084</address>
      <phone>+61 3 94965000</phone>
      <fax />
      <email>aaly@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ahmad Aly</name>
      <address>Department of Surgery
Austin Hospital
Level 8
Kance Townsend Building (LTB)
Studley Rd
Heidelberg VIC 3084</address>
      <phone>+61 3 94965000</phone>
      <fax />
      <email>aaly@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>